Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Demonstrated in rat models that combining a GHRP with GHRH produced GH pulse amplitudes 4-to-10-fold greater than GHRH alone [5]
No peptide protocol is appropriate
MSC cultured on matrices derived from fibroblasts exposed to control media showed a reduced capacity to differentiate to adipocytes, and this behavior was further exacerbated in matrices from fibroblasts incubated with LOX/BMP1
Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions
To get started, click here
Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis
